DHR
Danaher Corporation · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers):
holder breadth -3.2% ·
share flow -3.9% ·
net new positions -6.7%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 294.05K | $63.57M | n/a | −2 |
| Q2 2026 | 188 | +7 | 434.91M | $82.90B | +10 | −4 |
| Q1 2026 | 185 | -2 | 440.89M | $83.51B | +5 | −8 |
| Q4 2025 | 186 | -1 | 467.58M | $107.03B | +2 | −2 |
| Q3 2025 | 30 | -1 | 269.80M | $53.47B | +1 | −3 |
| Q2 2025 | 29 | +2 | 237.37M | $46.89B | +3 | −1 |
| Q1 2025 | 24 | -1 | 116.89M | $23.96B | +1 | −2 |
| Q4 2024 | 25 | +1 | 111.55M | $25.60B | +1 | n/a |
| Q3 2024 | 23 | +1 | 81.67M | $22.69B | +2 | −1 |
| Q2 2024 | 22 | n/a | 81.37M | $20.32B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 60.89M | +0.2% | $12.07B | 0.2% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passive) | 52.30M | +0.1% | $10.37B | 0.2% | ▲ Add | 2 | SEC ↗ ×22 |
| 3 | JPMorgan Chase ✦ | 37.28M | n/a | $7.39B | 0.2% | n/c | 1 | SEC ↗ ×42 |
| 4 | State Street Global Advisors ✦ (passive) | 27.21M | -0.3% | $5.40B | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 15.15M | +4.4% | $3.00B | 0.2% | ▲ Add | 2 | SEC ↗ ×7 |
| 6 | T. Rowe Price ✦ | 14.64M | -11.9% | $2.90B | 0.3% | ▼ Trim | 6 | SEC ↗ ×2 |
| 7 | Geode Capital Management ✦ (passive) | 13.85M | +0.9% | $2.73B | 0.2% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Wellington Management ✦ | 13.56M | -20.6% | $2.69B | 0.5% | ▼ Trim | 6 | SEC ↗ ×9 |
| 9 | Morgan Stanley ✦ | 11.61M | n/a | $2.30B | 0.1% | n/c | 1 | SEC ↗ ×23 |
| 10 | Goldman Sachs Group ✦ | 4.51M | n/a | $893.86M | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 11 | Fisher Asset Management ✦ | 4.37M | +0.7% | $866.24M | 0.3% | ▲ Add | 6 | SEC ↗ |
| 12 | Arrowstreet Capital ✦ | 3.52M | +33.9% | $697.68M | 0.4% | ▲ Add | 6 | SEC ↗ |
| 13 | Viking Global Investors ✦ | 2.75M | -5.4% | $545.46M | 1.4% | ▼ Trim | 3 | SEC ↗ |
| 14 | PRIMECAP Management ✦ | 1.45M | +17.0% | $287.46M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 1.46M | +65.1% | $276.28M | 0.2% | ▲ Add | 6 | SEC ↗ ×6 |
| 16 | Two Sigma Investments ✦ | 1.06M | -11.3% | $209.22M | 0.3% | ▼ Trim | 5 | SEC ↗ |
| 17 | Millennium Management ✦ | 927.58K | -49.2% | $183.90M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 648.60K | -50.1% | $128.59M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 19 | Adage Capital Partners ✦ | 555.50K | -44.6% | $110.13M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 20 | Capital World Investors ✦ | 489.01K | -87.3% | $96.95M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | Point72 Asset Management ✦ | 444.09K | -77.6% | $88.05M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 22 | Gates Foundation Trust ✦ | 373.00K | 0.0% | $73.95M | 0.2% | Held | 6 | SEC ↗ |
| 23 | Glenview Capital ✦ | 264.42K | +428.8% | $52.42M | 1.3% | ▲ Add | 2 | SEC ↗ |
| 24 | Citadel Advisors ✦ | 150.80K | +73.4% | $29.90M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 25 | Renaissance Technologies ✦ | 140.74K | New | $27.90M | 0.0% | New | 1 | SEC ↗ |
| 26 | Gotham Asset Management ✦ | 129.83K | +82.6% | $25.74M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 27 | Third Point ✦ | 50.00K | -90.0% | $9.91M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 28 | Dodge & Cox ✦ | 16.45K | -0.5% | $3.26M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 29 | Harris Associates (Oakmark) ✦ | 3.32K | +0.5% | $657,827 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 30 | GAMCO Investors ✦ | 1.60K | 0.0% | $317,216 | 0.0% | Held | 6 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $27.90M | 0.0% |
Exited
| Norges Bank | $1.98B | was 0.2% |
| Marshall Wace | $166.91M | was 0.2% |
| Duquesne Family Office | $4.88M | was 0.1% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2,147 holders, 548.39M shares, $97.77B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, Director · 11.31K sh · $2.46M
Officer, Director · 39.19K sh · $8.57M
Officer, Director · 7.75K sh · $1.70M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology